US Bancorp’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-17
| Closed | -$398 | – | 4339 |
|
|
2025
Q4 | $398 | Buy |
+17
| New | +$369 | ﹤0.01% | 3939 |
|
|
2025
Q1 | – | Sell |
-47
| Closed | -$501 | – | 4367 |
|
|
2024
Q4 | $501 | Hold |
47
| – | – | ﹤0.01% | 4021 |
|
|
2024
Q3 | $597 | Sell |
47
-123
| -72% | -$1.83K | ﹤0.01% | 3938 |
|
|
2024
Q2 | $2.85K | Buy |
170
+36
| +27% | +$512 | ﹤0.01% | 3645 |
|
|
2024
Q1 | $2.01K | Hold |
134
| – | – | ﹤0.01% | 3725 |
|
|
2023
Q4 | $2.01K | Buy |
+134
| New | +$1.74K | ﹤0.01% | 3702 |
|
|
2022
Q1 | – | Sell |
-605
| Closed | -$6K | – | 4203 |
|
|
2021
Q4 | $6K | Buy |
605
+209
| +53% | +$2.95K | ﹤0.01% | 3605 |
|
|
2021
Q3 | $6K | Buy |
396
+215
| +119% | +$3.41K | ﹤0.01% | 3605 |
|
|
2021
Q2 | $3K | Sell |
181
-1,294
| -88% | -$23.4K | ﹤0.01% | 3765 |
|
|
2021
Q1 | $29K | Sell |
1,475
-435
| -23% | -$9.23K | ﹤0.01% | 2862 |
|
|
2020
Q4 | $35K | Buy |
1,910
+659
| +53% | +$13.8K | ﹤0.01% | 2666 |
|
|
2020
Q3 | $24K | Buy |
1,251
+918
| +276% | +$20.8K | ﹤0.01% | 2743 |
|
|
2020
Q2 | $9K | Buy |
333
+48
| +17% | +$1.17K | ﹤0.01% | 3139 |
|
|
2020
Q1 | $5K | Buy |
285
+138
| +94% | +$3.73K | ﹤0.01% | 3277 |
|
|
2019
Q4 | $5K | Buy |
147
+11
| +8% | +$300 | ﹤0.01% | 3291 |
|
|
2019
Q3 | $3K | Hold |
136
| – | – | ﹤0.01% | 3362 |
|
|
2019
Q2 | $5K | Hold |
136
| – | – | ﹤0.01% | 3295 |
|
|
2019
Q1 | $5K | Hold |
136
| – | – | ﹤0.01% | 3256 |
|
|
2018
Q4 | $6K | Sell |
136
-34
| -20% | -$1.53K | ﹤0.01% | 3175 |
|
|
2018
Q3 | $8K | Buy |
+170
| New | +$7.9K | ﹤0.01% | 3206 |
|
Other funds holding URGN
RI
KCM
JFG
PBA
ACA
